Predicting osimertinib outcomes in NSCLC using liquid biopsy RWD

ctDNA EGFR status predicts worse survival in NSCLC patients on Osimertinib

INDICATION

Lung

BIOMARKER

EGFR

Related cases

Visual representation of a sparse, abstract data pattern using shaded dots.

IL33 expression as a predictor of immunotherapy response in NSCLC

Scientific data visualization with a grid of blue, purple, and green points forming diagonal patterns.

Impact of B cell and CD8 T cell infiltration on immunotherapy outcomes in NSCLC

Unable to determine image content.

Impact of VEGF expression on pembrolizumab outcomes in mNSCLC